v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total revenue $ 3,604,000 $ 5,285,000 $ 7,934,000 $ 10,237,000
Costs and expenses:        
Cost of revenue 4,519,000 5,489,000 10,052,000 10,665,000
Selling, general and administrative (including stock-based compensation) 2,871,000 3,221,000 7,156,000 6,723,000
Total costs and expenses 7,390,000 8,710,000 17,208,000 17,388,000
Operating loss (3,786,000) (3,425,000) (9,274,000) (7,151,000)
Other income (expense):        
Interest income 2,000 13,000 3,000 17,000
Interest income on note receivable, related party 6,000 12,000 12,000 16,000
Dividend income 5,000 16,000
Other income (expense) 21,000 4,000 7,000 10,000
Interest expense (89,000) (123,000) (128,000) (156,000)
Loss on equity method investment (364,000) (2,000) (367,000) (5,000)
(Loss) gain on investments (830,000) 1,557,000 (1,531,000) 627,000
Impairment of intangible assets (600,000) (600,000)
Loss on sale of real estate (43,000) (727,000)
Loss from continuing operations before income taxes (5,035,000) (2,607,000) (11,262,000) (7,969,000)
Income tax benefit 67,000
Net loss (5,035,000) (2,607,000) (11,262,000) (7,902,000)
Loss from operations attributed to noncontrolling interest 246,000 455,000 873,000 973,000
Net loss attributable to DSS common stockholders $ (4,789,000) $ (2,152,000) $ (10,389,000) $ (6,929,000)
Loss per common share attributable to common stock holders        
Basic $ (0.48) $ (0.24) $ (1.06) $ (0.78)
Diluted $ (0.48) $ (0.24) $ (1.06) $ (0.78)
Shares used in computing loss per common share:        
Basic 10,042,518 9,092,518 9,847,214 8,889,221
Diluted 10,042,518 9,092,518 9,847,214 8,889,221
Printed Products [Member]        
Revenue:        
Total revenue $ 3,258,000 $ 4,272,000 $ 7,405,000 $ 8,255,000
Rental [Member]        
Revenue:        
Total revenue 245,000 715,000 392,000 1,429,000
Commercial Lending [Member]        
Revenue:        
Total revenue 6,000 9,000 12,000 29,000
Commission [Member]        
Revenue:        
Total revenue 92,000 282,000 115,000 503,000
Biotechnology [Member]        
Revenue:        
Total revenue $ 3,000 $ 7,000 $ 10,000 $ 21,000